| Trial ID: | L0779 |
| Source ID: | IRCT20180404039187N2
|
| Associated Drug: |
Allopurinol
|
| Title: |
study the effects of Allopurinol on liver enzymes and grade of fatty liver on ultrasound in patients with non-alcoholic fatty liver disease
|
| Acronym: |
--
|
| Status: |
Not Recruiting
|
| Study Results: |
No Results Available
|
| Results: |
--
|
| Conditions: |
non-alcoholic fatty liver disease. <br>Fatty (change of) liver, not elsewhere classified
|
| Interventions: |
Intervention 1: Intervention group: consumption of 100 mg Allopurinol daily for 6 months. Intervention 2: Control group: routin care.
|
| Outcome Measures: |
Serum liver enzymes AST and ALT and grade of fatty liver based on ultrasound. Timepoint: at the beginning and 3 and 6 months later. Method of measurement: laboratory tests and ultrasound.nan
|
| Sponsor/Collaborators: |
Tabriz University of Medical Sciences
|
| Gender: |
All
|
| Age: |
18 years65 years
|
| Phases: |
Phase 3
|
| Enrollment: |
100
|
| Study Type: |
interventional
|
| Study Designs: |
Randomization: Randomized, Blinding: Double blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment, Randomization description: Arrange the accident stages:
1) Determine the volume of each block (Foursquare blocks)
2) Prepare block lists and
|
| Start Date: |
23/11/2018
|
| Completion Date: |
--
|
| Results First Posted: |
--
|
| Last Update Posted: |
14 January 2019
|
| Locations: |
Iran (Islamic Republic of)
|
| URL: |
http://en.irct.ir/trial/32805
|
